JP2024009968A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024009968A5 JP2024009968A5 JP2023177575A JP2023177575A JP2024009968A5 JP 2024009968 A5 JP2024009968 A5 JP 2024009968A5 JP 2023177575 A JP2023177575 A JP 2023177575A JP 2023177575 A JP2023177575 A JP 2023177575A JP 2024009968 A5 JP2024009968 A5 JP 2024009968A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- solvate
- acceptable salt
- prodrug
- antimicrobial compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 claims 24
- 239000012453 solvate Substances 0.000 claims 24
- 239000003814 drug Substances 0.000 claims 17
- 239000004599 antimicrobial Substances 0.000 claims 16
- 229940002612 prodrug Drugs 0.000 claims 15
- 239000000651 prodrug Substances 0.000 claims 15
- 229940124597 therapeutic agent Drugs 0.000 claims 11
- 229940024554 amdinocillin Drugs 0.000 claims 9
- 229940106164 cephalexin Drugs 0.000 claims 9
- BWWVAEOLVKTZFQ-ISVUSNJMSA-N chembl530 Chemical compound N(/[C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)=C\N1CCCCCC1 BWWVAEOLVKTZFQ-ISVUSNJMSA-N 0.000 claims 9
- HGGAKXAHAYOLDJ-FHZUQPTBSA-N 6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid Chemical compound S([C@@H]1[C@H](C(N1C=1C(O)=O)=O)[C@H](O)C)C=1[C@H]1CCCO1 HGGAKXAHAYOLDJ-FHZUQPTBSA-N 0.000 claims 7
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims 7
- 229960000379 faropenem Drugs 0.000 claims 7
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 claims 7
- 229960000308 fosfomycin Drugs 0.000 claims 7
- 208000027096 gram-negative bacterial infections Diseases 0.000 claims 5
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 claims 5
- 229960002555 zidovudine Drugs 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 4
- 230000000845 anti-microbial effect Effects 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 241000588724 Escherichia coli Species 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- -1 cephalexin phthalidyl ester Chemical class 0.000 claims 2
- NPGNOVNWUSPMDP-UTEPHESZSA-N chembl1650818 Chemical compound N(/[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)OCOC(=O)C(C)(C)C)=C\N1CCCCCC1 NPGNOVNWUSPMDP-UTEPHESZSA-N 0.000 claims 2
- JQBKWZPHJOEQAO-DVPVEWDBSA-N faropenem medoxil Chemical compound S([C@@H]1[C@H](C(N1C=1C(=O)OCC2=C(OC(=O)O2)C)=O)[C@H](O)C)C=1[C@H]1CCCO1 JQBKWZPHJOEQAO-DVPVEWDBSA-N 0.000 claims 2
- 229950009817 faropenem medoxil Drugs 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229960004212 pivmecillinam Drugs 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 208000019206 urinary tract infection Diseases 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1807046.6A GB201807046D0 (en) | 2018-04-30 | 2018-04-30 | Combination |
| GB1807046.6 | 2018-04-30 | ||
| PCT/GB2019/051062 WO2019211576A1 (en) | 2018-04-30 | 2019-04-12 | Combination comprising zidovudine and an antimicrobial compound |
| JP2020560822A JP7412008B2 (ja) | 2018-04-30 | 2019-04-12 | ジドブジン及び抗微生物化合物を含む組み合わせ |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560822A Division JP7412008B2 (ja) | 2018-04-30 | 2019-04-12 | ジドブジン及び抗微生物化合物を含む組み合わせ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024009968A JP2024009968A (ja) | 2024-01-23 |
| JP2024009968A5 true JP2024009968A5 (enExample) | 2024-03-01 |
| JP7577376B2 JP7577376B2 (ja) | 2024-11-05 |
Family
ID=62494998
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560822A Active JP7412008B2 (ja) | 2018-04-30 | 2019-04-12 | ジドブジン及び抗微生物化合物を含む組み合わせ |
| JP2023177575A Active JP7577376B2 (ja) | 2018-04-30 | 2023-10-13 | ジドブジン及び抗微生物化合物を含む組み合わせ |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560822A Active JP7412008B2 (ja) | 2018-04-30 | 2019-04-12 | ジドブジン及び抗微生物化合物を含む組み合わせ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11951119B2 (enExample) |
| EP (1) | EP3787622B1 (enExample) |
| JP (2) | JP7412008B2 (enExample) |
| CN (1) | CN112218633A (enExample) |
| CA (1) | CA3096575C (enExample) |
| GB (1) | GB201807046D0 (enExample) |
| PL (1) | PL3787622T3 (enExample) |
| WO (1) | WO2019211576A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201913068D0 (en) * | 2019-09-10 | 2019-10-23 | Helperby Therapeutics Ltd | Combination |
| CN114196586B (zh) * | 2021-12-20 | 2023-04-11 | 郑州大学 | 一株蒙氏肠球菌及其在发酵中草药中的应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000028074A1 (en) | 1998-11-09 | 2000-05-18 | St. George's Enterprises Limited | Screening process for antibacterial agents |
| US6521270B1 (en) | 2001-06-11 | 2003-02-18 | The Procter & Gamble Company | Compositions comprising nitrofurantoin and uva ursi |
| US7410974B2 (en) | 2003-08-08 | 2008-08-12 | Ulysses Pharmaceutical Products, Inc. | Halogenated Quinazolinyl nitrofurans as antibacterial agents |
| JP2005239696A (ja) * | 2004-01-30 | 2005-09-08 | Daiichi Suntory Pharma Co Ltd | 無機物質を配合した医薬硬質カプセル剤 |
| US20080226614A1 (en) * | 2004-08-23 | 2008-09-18 | Krishna Murthy Ella | Eukaryotic Based Synergistic Formulation for Gastro-Intestinal Disorders |
| US20060073173A1 (en) * | 2004-10-04 | 2006-04-06 | Maria Banach | Large-scale manufacturing process for the production of pharmaceutical compositions |
| GB201305277D0 (en) | 2013-03-22 | 2013-05-01 | Helperby Therapeutics Ltd | Novel combination and use |
| GB201401617D0 (en) | 2014-01-30 | 2014-03-19 | Helperby Therapeutics Ltd | Novel combination and use |
| DE102014218913A1 (de) * | 2014-09-19 | 2016-03-24 | Heraeus Medical Gmbh | Verfahren zur Herstellung eines antibiotischen Polymehtylmethacrylat-Knochenzementpulvers und ein antibiotisches Polymethtylmethacrylat-Knochenzementpulver |
| GB201521771D0 (en) | 2015-12-10 | 2016-01-27 | Helperby Therapeutics Ltd | Formulation |
| GB201612093D0 (en) | 2016-07-12 | 2016-08-24 | Helperby Therapeutics Ltd | Combination |
-
2018
- 2018-04-30 GB GBGB1807046.6A patent/GB201807046D0/en not_active Ceased
-
2019
- 2019-04-12 WO PCT/GB2019/051062 patent/WO2019211576A1/en not_active Ceased
- 2019-04-12 PL PL19718838.6T patent/PL3787622T3/pl unknown
- 2019-04-12 US US17/051,549 patent/US11951119B2/en active Active
- 2019-04-12 EP EP19718838.6A patent/EP3787622B1/en active Active
- 2019-04-12 CN CN201980029422.2A patent/CN112218633A/zh active Pending
- 2019-04-12 CA CA3096575A patent/CA3096575C/en active Active
- 2019-04-12 JP JP2020560822A patent/JP7412008B2/ja active Active
-
2023
- 2023-10-13 JP JP2023177575A patent/JP7577376B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6483058B2 (ja) | 抗菌剤と分散剤または接着阻害剤組成物 | |
| JP2024009968A5 (enExample) | ||
| JP5410748B2 (ja) | 抗菌剤およびカルベオール、チモール、オイゲノール、ボルネオールならびにカルバクロールから選択される活性成分を含んでなる医薬組成物 | |
| JP5470245B2 (ja) | バイオフィルム形成の処置のためのトリアゾール化合物 | |
| JP2018500387A5 (enExample) | ||
| JP6480870B2 (ja) | 細菌感染を処置するための組成物および方法 | |
| RU2018107150A (ru) | Новый эффективный аминогликозидный антибиотик против бактерий с множественной лекарственной резистентностью | |
| RU2646798C2 (ru) | Антибактериальные композиции | |
| JP5276653B2 (ja) | カルバペネム類を含む殺菌性抗ｍｒｓａ活性医薬組成物 | |
| JP5767745B2 (ja) | 抗菌剤とタゾバクタムとを含む組成物 | |
| CN105792827B (zh) | 抗菌组合物 | |
| JP2017507162A (ja) | 抗菌薬を含む医薬組成物 | |
| US20230398139A1 (en) | Methods and compositions for treating carbapenem-resistant klebsiella pneumoniae infections | |
| JP2017511359A (ja) | 抗菌薬を含む医薬組成物 | |
| JP6626516B2 (ja) | 抗菌組成物及び方法 | |
| Sagar et al. | Era of Antibiotic Discovery | |
| JP7758906B2 (ja) | セラチオペプチダーゼ、マンノースまたはその誘導体および任意に抗感染薬剤を使用する医薬組成物ならびに処置の方法 | |
| CN111249292B (zh) | 一种抗菌药物组合物及其制备方法和用途 | |
| JP2017508769A (ja) | セフェピムまたはスルバクタムを含む医薬組成物 | |
| JP2014530908A (ja) | 細菌性感染症の治療のための医薬組成物及びキット | |
| NZ740037B2 (en) | New effective aminoglycoside antibiotic for multidrug-resistant bacteria |